Competitive Binding
Competitive Binding - Related Videos
04:05
Competition Binding Assay to Study Competing GTPase-Binding Protein Partners
0 Views •
2025
This video demonstrates a competition assay to study GTPase-binding protein partners. Utilizing nucleotide-bound GTPase protein immobilized on magnetic beads, the competitive binding between two interacting protein partners for the same binding site on the GTPase can be studied to assess the binding affinities of the protein partners.
10:37
Comparing the Affinity of GTPase-binding Proteins using Competition Assays
0 Views •
Cited by 2 •
2015
This protocol compares the relative affinities of binding partners for Rho-family GTPases, including Rac1. In vivo, Rac1-binding proteins compete for a single binding interface, the conformation of which is dictated by a bound nucleotide. The nucleotide is both important and difficult to control experimentally, due to the high hydrolysis rate.
06:27
Competitive Binding Assay to Identify Compounds Disrupting Receptor-Ligand Interactions
0 Views •
2025
In this video, we describe a flow cytometry-based competitive binding assay to detect the interactions between the CXC Chemokine Receptor 4 (CXCR4) and its fluorescently-labeled natural ligand CXC Chemokine Ligand 12 (CXCL12), in the presence of a CXCR4-targeting small molecule. Incubating CXCR4-expressing cells with lower small molecule concentrations allows CXCR4-CXCL12 binding to some extent, which progressively declines upon a gradual increase in small molecule concentrations.
08:40
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
0 Views •
Cited by 40 •
2016
The presented protocols describe two enzyme-linked immunosorbent assay (ELISA) based techniques for the rapid investigation of ligand-receptor interactions: The first assay allows the determination of dissociation constant between ligand and receptor. The second assay enables a rapid screening of blocking peptides for ligand-receptor interactions.
14:22
ELISA Assays: Indirect, Sandwich, and Competitive
0 Views •
2023
Source: Whitney Swanson1,2, Frances V. Sjaastad2,3, and Thomas S. Griffith1,2,3,4 1 Department of Urology, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Enzyme-linked immunosorbent assay (ELISA) is frequently used to measure the presence...
FAQs
The balance depends on both how much of each ligand is present and how strongly each ligand binds the shared target. A ligand with greater affinity can compete effectively at lower concentration, whereas increasing the concentration of a competing ligand can reduce another ligand’s access. Considering both variables helps explain changes in receptor occupancy and drug response.
Because the competitor binds reversibly, the interaction reflects a shifting equilibrium rather than permanent removal of the target. Changes in ligand concentrations can therefore alter which substance occupies the binding site. This feature helps explain why the observed effect may change when drug levels, competing endogenous molecules, or other ligand concentrations vary.
A competitor can reduce the opportunity for an agonist or antagonist to occupy its receptor site. For an agonist, this may alter receptor signaling by changing access to the target; for an antagonist, it can influence how effectively receptor activation is opposed. Endogenous molecules can also participate in these interactions, contributing to variation in pharmacological responses.
Competitive binding focuses on the molecular competition for a shared target site, whereas receptor signaling concerns the functional consequences that follow target engagement. Binding information can therefore help explain why signaling changes, but occupancy and response are not identical measurements. Separating these levels supports clearer interpretation of how ligand interactions relate to observed drug effects.
A competitive binding assay can be used to measure ligand affinity and characterize receptor populations. Comparing how ligands compete provides information about their relative interactions with the target, while receptor characterization helps describe the population available for binding. These results support interpretation of drug action and provide evidence for evaluating candidate compounds.
The approach is useful when researchers need to compare ligand affinity, investigate receptor populations, or anticipate competition between medications and endogenous molecules. In drug discovery, these measurements help evaluate how candidate substances interact with a target. In pharmacology, the same principles support dose interpretation and prediction of interactions that may influence drug responses.